Informing patients with cancer of "new findings" that may influence their willingness to participate in research studies.
Markman
Maurie
M
Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA. markmam@ccf.org
D000970:Antineoplastic Agents / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D016190:Carboplatin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007258:Informed Consent; D010051:Ovarian Neoplasms / Q000188:drug therapy; D017239:Paclitaxel / Q000627:therapeutic use; D010358:Patient Participation; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D014342:Truth Disclosure
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D016190:Carboplatin; D017239:Paclitaxel